Monty Pal

In this insightful discussion, Dr. Monty Pal, a medical oncologist from City of Hope, shares his expertise on renal cell carcinoma treatment. He dives into the nuances of managing toxicities from tyrosine kinase inhibitors (TKIs) and HIF-2 alpha inhibitors, offering practical dosing strategies. The conversation highlights common side effects like hypertension and fatigue, and Dr. Pal provides invaluable clinical pearls for mitigating these issues while maintaining patients' quality of life. Discover effective management techniques for both first- and second-line therapies!